A rendering of Bristol Myers Squibb's new Cambridge site (DivcoWest)

Bris­tol My­ers adds on at Cam­bridge Cross­ing, set­tling in even fur­ther in bustling Boston-area biotech hub

In the sum­mer of 2020, Bris­tol My­ers Squibb un­veiled plans to plant its flag in the bustling bio­phar­ma Cam­bridge Cross­ing cam­pus on the bor­der of Cam­bridge, Boston and neigh­bor­ing Somerville. Now, the Big Phar­ma is dou­bling down on that move and giv­ing it­self a lit­tle ex­tra el­bow room to boot.

Last week, BMS ex­pand­ed its lease to in­clude the re­main­ing eighth and ninth floors of its build­ing at Cam­bridge Cross­ing, a move that en­sures “fu­ture flex­i­bil­i­ty,” the com­pa­ny said in a state­ment to End­points News.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.